CervoMed Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 1.53 million. Net income was USD 2.15 million compared to net loss of USD 0.882623 million a year ago. Basic earnings per share from continuing operations was USD 0.65. Diluted loss per share from continuing operations was USD 0.7.
For the nine months, sales was USD 4.65 million. Net income was USD 0.190525 million compared to net loss of USD 4.28 million a year ago. Basic earnings per share from continuing operations was USD 0.13. Diluted loss per share from continuing operations was USD 2.37.